Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.19.2
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Jun. 30, 2019
Dec. 31, 2018
Current assets:    
Cash and cash equivalents $ 16,795 $ 87,721
Marketable securities, current 55,529 10,234
Prepaid expenses 2,258 2,244
Grants revenue receivable 5,160 4,329
Accounts receivable from related party 0 240
Other current assets 98 95
Total current assets 79,840 104,863
Operating lease right-of-use assets, non-current 10,796 0
Property and equipment, net 9,151 6,851
In-process research and development 26,623 26,623
Other assets 4,737 1,821
Total assets 131,147 140,158
Current liabilities:    
Accounts payable 2,577 780
Accrued liabilities 7,120 5,357
Deferred revenue, current 14,561 26,231
Other current liabilities 1,435 141
Total current liabilities 25,693 32,509
Deferred revenue, non-current 1,664 2,670
Long-term debt, non-current, net 3,075 3,254
Operating lease liabilities, non-current 10,707 0
Other liabilities 748 819
Total liabilities 41,887 39,252
Commitments and contingencies (Note 9)
Stockholders’ equity    
Common stock, $0.001 par value: Authorized: 150,000,000 shares; issued and outstanding: 36,882,163 shares at June 30, 2019 and 36,736,012 shares at December 31, 2018 37 37
Additional paid-in capital 199,223 195,573
Accumulated other comprehensive income 25 0
Accumulated deficit (110,025) (94,704)
Total stockholders’ equity 89,260 100,906
Total liabilities and stockholders’ equity $ 131,147 $ 140,158